<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02854241</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-2016-0174</org_study_id>
    <nct_id>NCT02854241</nct_id>
  </id_info>
  <brief_title>Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance</brief_title>
  <official_title>Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging as a Surveillance Test for HCC in Patients With Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate clinical feasibility of annual non-contrast
      magnetic resonance imaging for surveillance of hepatocellular carcinoma in high-risk group,
      in comparison with biannual ultrasonography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to investigate clinical feasibility of annual non-contrast
      magnetic resonance imaging for surveillance of hepatocellular carcinoma in high-risk group,
      in comparison with biannual ultrasonography. In addition, the relationship between
      non-contrast MR parameters and clinical manifestation of liver function is investigated.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>sensitivity for detecting HCC</measure>
    <time_frame>6 months after last patient's MRI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>specificity for detecting HCC</measure>
    <time_frame>6 months after last patient's MRI</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Apparent diffusion coefficient (ADC)</measure>
    <time_frame>1 month after each MR scan</time_frame>
    <description>calculated value from diffusion weighted image with different protocols (conventional, simultaneous multishot)</description>
  </other_outcome>
  <other_outcome>
    <measure>T2 relaxation time</measure>
    <time_frame>1 month after MR scan</time_frame>
    <description>calculated value from T2 map</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>LC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LC group under surveillance of biannual ultrasonography and annual noncontrast liver MRI. Six month after the last MRI, contrast enhanced liver CT is performed to investigate presence of HCC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biannual ultrasonography</intervention_name>
    <description>Biannual ultrasonography for HCC surveillance, performed by board-certified radiologists.</description>
    <arm_group_label>LC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Annual noncontrast liver MRI</intervention_name>
    <description>Annual noncontrast liver MRI consisted of T2WI, precontrast T1WI, dual-echo image, DWI (single shot, multishot) and T2 map.
DWI using multishot and T2 map are not included for initial MR reading.</description>
    <arm_group_label>LC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contrast enhanced liver CT</intervention_name>
    <description>In patients without report of HCC during surveillance period, contrast CT is performed 6 months after the last MR scan.</description>
    <arm_group_label>LC group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  equal to or older than 40 years

          -  under surveillance using biannual ultrasonography (USG) and presence of liver USG
             within 6 months (+/- 1month)

          -  risk index is equal to or higher than 2.33 (Risk Index = 1.65 (if the prothrombin
             activity is &lt;=75%) + 1.41 (if the age is 50 years or older) + 0.92 (if the platelet
             count is &lt;=100x10(3)/mm3) + 0.74 (if the presence of HCV or HBsAg is positive)).

          -  signed informed consent

        Exclusion Criteria:

          -  under 40 years

          -  history of HCC

          -  patients with pregnancy or nursing

          -  any contraindication of MRI

          -  any contraindication of CT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeong Min Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2016</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Min Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>HCC</keyword>
  <keyword>surveillance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

